**Core Concept**
Tangier disease is a rare inherited disorder characterized by a deficiency of apolipoprotein A-I (ApoA-I), which is a major component of high-density lipoprotein (HDL) particles. This deficiency leads to impaired cholesterol efflux from cells to HDL, resulting in accumulation of cholesterol esters in various tissues, including the liver, spleen, and peripheral tissues.

**Why the Correct Answer is Right**
The primary pathophysiological mechanism underlying Tangier disease is the impaired function of the ATP-binding cassette transporter A1 (ABCA1), which is responsible for the efflux of cholesterol and phospholipids from cells to ApoA-I containing HDL particles. In Tangier disease, the decreased ApoA-I levels lead to reduced ABCA1 activity, resulting in impaired cholesterol efflux and accumulation of cholesterol esters in tissues. This accumulation can lead to organ dysfunction and increased risk of atherosclerosis.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as Tangier disease is not primarily associated with elevated levels of low-density lipoprotein (LDL) cholesterol.
**Option B:** This option is incorrect as Tangier disease is not characterized by the accumulation of triglycerides in the blood.
**Option C:** This option is incorrect as Tangier disease is not primarily associated with the activation of the renin-angiotensin-aldosterone system (RAAS).

**Clinical Pearl / High-Yield Fact**
Tangier disease highlights the importance of HDL in lipid metabolism and atherosclerosis prevention. It serves as a reminder that HDL is not just a "good" cholesterol, but a critical component in the regulation of cholesterol efflux and atherosclerotic plaque formation.

**Correct Answer:** D.